Top Feature

Feb 01, 2013
Pharmaceutical Executive
After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports.
Dec 01, 2012
Pharmaceutical Executive
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
Nov 05, 2012
By Pharmaceutical Executive Editors
If we swallow the hype and decide that we all need to get onto the mobile app bandwagon, how exactly do we go about it? Sven Awege explains.
Oct 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharmaceutical companies looking to wrest market share in high growth markets of tomorrow must overcome challenges from a new crop of national champions.
Sep 01, 2012
Pharmaceutical Executive
Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions.
Jul 30, 2012
Are there parallels between milk and medicine? To David Ford, a native New Zealander who now runs Sanofi's North America human resources operations, the answer is a qualified yes.
Jul 24, 2012
By Pharmaceutical Executive Editors
Pharma's Baby Boomer era is over — now it's the Generation X-ers' turn, says Georg Toufar, Chief Marketing Officer and Board Director of Mundipharma International Limited.
Jul 18, 2012
Eric Dube, one of this years Pharm Exec Emerging Pharma Leaders, is not yet 40 and is now GSK's senior VP of strategy after already holding seven "very different" roles at the company.
Jul 04, 2012
By Pharmaceutical Executive Editors
It's good to look to other industries such as FMCG — and to products such as Pepsi and Horlicks — for lessons in emerging market success, writes Nick Stephens.
Jun 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
As brands are required to produce more and more data to convince not only regulators, but payers, physicians, and patients, Jeffrey Jonas is pushing Shire's "search and develop" R&D model into new and sometimes uncomfortable territory.
native1_300x100
lorem ipsum